Page 4 - Rensselaer Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rensselaer center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rensselaer Center Today - Breaking & Trending Today

Effect of COVID-19 Antiviral Remdesivir Multiplied 10-Fold by Hepatitis C Drugs


Effect of COVID-19 Antiviral Remdesivir Multiplied 10-Fold by Hepatitis C Drugs
Effect of COVID-19 Antiviral Remdesivir Multiplied 10-Fold by Hepatitis C Drugs
Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures. [Jenna Luecke/University of Texas at Austin]
April 27, 2021
Share
Remdesivir, the only antiviral drug approved in the United States for treating COVID-19 patients, is up to 10 times more effective when it is mixed with a repurposed hepatitis C drug. The effect has been observed with several hepatitis C drugs namely, simeprevir, grazoprevir, paritaprevir, and vaniprevir. All four appear to have the same remdesivir-boosting mechanism: inhibition of the SARS-CoV-2 papain-like protease (PL ....

United States , Arthurm Fishberg , Robertm Krug , Adolfo Garc , Gaetanot Montelione , Pathogens Institute At Icahn Mount Sinai , Icahn School Of Medicine At Mount Sinai , Global Health , Rensselaer Polytechnic Institute , University Of Texas , Rensselaer Center , Icahn School , Mount Sinai , Like Protease Synergize , Suppress Viral Replication , Cell Reports , Cell Culture , Emerging Pathogens Institute , Icahn Mount , ஒன்றுபட்டது மாநிலங்களில் , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , உலகளாவிய ஆரோக்கியம் , ரென்சீலர் பாலிடெக்நிக் நிறுவனம் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் , ரென்சீலர் மையம் , இக்ஹ்ன் பள்ளி ,